Interleukin-1 receptors are differentially expressed in normal and psoriatic T cells

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Bebes, Attila ^a   Kovács Sólyom, Ferenc ^a   Prihoda, Judit ^a   Kui, Róbert ^a   Kemény, Lajos ^a   Gyulai, Rolland ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1 RECEPTOR TYPE II; S INTERLEUKIN 1 RECEPTOR TYPE II; UNCLASSIFIED DRUG; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA; MESSENGER RNA;

ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMORY T LYMPHOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC T CELL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T CELL CULTURE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; CASE CONTROL STUDY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM;

CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; PSORIASIS; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84896290882     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/472625     Document Type: Article

References (33)

1. Lowes M. A., Bowcock A. M., Krueger J. G., Pathogenesis and therapy of psoriasis. Nature 2007 445 7130 866 873 2-s2.0-33847279025 10.1038/nature05663
2. Nestle F. O., Kaplan D. H., Barker J., Psoriasis. The New England Journal of Medicine 2009 361 5 496 509 2-s2.0-68049131637 10.1056/NEJMra0804595
3. Nograles K. E., Davidovici B., Krueger J. G., New insights in the immunologic basis of psoriasis. Seminars in Cutaneous Medicine and Surgery 2010 29 1 3 9 2-s2.0-77951565421 10.1016/j.sder.2010.03.001
4. Baker B. S., Swain A. F., Valdimarsson H., Fry L., T-cell subpopulations in the blood and skin of patients with psoriasis. British Journal of Dermatology 1984 110 1 37 44 2-s2.0-0021332936 10.1111/j.1365-2133.1984.tb07309.x (Pubitemid 14212916)
5. Ghoreschi K., Weigert C., Röcken M., Immunopathogenesis and role of T cells in psoriasis. Clinics in Dermatology 2007 25 6 574 580 2-s2.0-36048946615 10.1016/j.clindermatol.2007.08.012 (Pubitemid 350087604)
6. Weinstein G. D., Frost P., Abnormal cell proliferation in psoriasis. Journal of Investigative Dermatology 1968 50 3 254 259 2-s2.0-0014258389
7. Renne J., Schäfer V., Werfel T., Wittmann M., Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation. British Journal of Dermatology 2010 162 6 1198 1205 2-s2.0-77952714051 10.1111/j.1365-2133.2010. 09662.x
8. Tonel G., Conrad C., Interplay between keratinocytes and immune cells-recent insights into psoriasis pathogenesis. The International Journal of Biochemistry & Cell Biology 2009 41 5 963 968 2-s2.0-59649105640 10.1016/j.biocel.2008.10.022
9. Dinarello C. A., Immunological and inflammatory functions of the interleukin-1 family. Annual Review of Immunology 2009 27 519 550 2-s2.0-62649139025 10.1146/annurev.immunol.021908.132612
10. Cooper K. D., Hammerberg C., Baadsgaard O., Elder J. T., Chan L. S., Taylor R. S., Voorhees J. J., Fisher G., Interleukin-1 in human skin: dysregulation in psoriasis. Journal of Investigative Dermatology 1990 95 5 24S 26S 2-s2.0-0025225424
11. Jensen L. E., Targeting the IL-1 family members in skin inflammation. Current Opinion in Investigational Drugs 2010 11 11 1211 1220 2-s2.0-78650384038
12. +CD2 5 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. The Journal of Immunology 2005 174 1 164 173 2-s2.0-10844222790 (Pubitemid 40007402)
13. Chung Y., Chang S. H., Martinez G. J., Yang X. O., Nurieva R., Kang H. S., Ma L., Watowich S. S., Jetten A. M., Tian Q., Dong C., Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009 30 4 576 587 2-s2.0-64049089798 10.1016/j.immuni.2009.02.007
14. Goodman W. A., Levine A. D., Massari J. V., Sugiyama H., McCormick T. S., Cooper K. D., IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. The Journal of Immunology 2009 183 5 3170 3176 2-s2.0-70349241839 10.4049/jimmunol.0803721
15. Mercer F., Kozhaya L., Unutmaz D., Expression and function of TNF and IL-1 receptors on human regulatory T cells. PloS ONE 2010 5 1, article e8639 2-s2.0-77952505225 10.1371/journal.pone.0008639
16. + regulatory T cells. Trends in Immunology 2006 27 12 541 544 2-s2.0-33751207432 10.1016/j.it.2006.10.002 (Pubitemid 44780852)
17. Nickoloff B. J., Qin J.-Z., Nestle F. O., Immunopathogenesis of psoriasis. Clinical Reviews in Allergy & Immunology 2007 33 1-2 45 56 2-s2.0-39649113592 10.1007/s12016-007-0039-2 (Pubitemid 351514147)
18. Boyman O., Conrad C., Tonel G., Gilliet M., Nestle F. O., The pathogenic role of tissue-resident immune cells in psoriasis. Trends in Immunology 2007 28 2 51 57 2-s2.0-33846616821 10.1016/j.it.2006.12.005 (Pubitemid 46176734)
19. Lee E., Trepicchio W. L., Oestreicher J. L., Pittman D., Wang F., Chamian F., Dhodapkar M., Krueger J. G., Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. The Journal of Experimental Medicine 2004 199 1 125 130 2-s2.0-0347285359 10.1084/jem.20030451 (Pubitemid 38076484)
20. Lowes M. A., Kikuchi T., Fuentes-Duculan J., Cardinale I., Zaba L. C., Haider A. S., Bowman E. P., Krueger J. G., Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. Journal of Investigative Dermatology 2008 128 5 1207 1211 2-s2.0-42149087160 10.1038/sj.jid.5701213 (Pubitemid 351543220)
21. Romer J., Hasselager E., Nørby P. L., Steiniche T., Clausen J. T., Kragballe K., Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. Journal of Investigative Dermatology 2003 121 6 1306 1311 2-s2.0-0346364791 10.1111/j.1523-1747.2003.12626.x (Pubitemid 38005477)
22. Wolk K., Witte E., Warszawska K., Schulze-Tanzil G., Witte K., Philipp S., Kunz S., Döcke W.-D., Asadullah K., Volk H.-D., Sterry W., Sabat R., The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. European Journal of Immunology 2009 39 12 3570 3581 2-s2.0-73249116548 10.1002/eji.200939687
23. Fincham N. J., Camp R. D. R., Gearing A. J. H., Bird C. R., Cunningham F. M., Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterization. The Journal of Immunology 1988 140 12 4294 4299 2-s2.0-0023718227
24. Mee J. B., Cork M. J., di Giovine F. S., Duff G. W., Groves R. W., Interleukin-1: a key inflammatory mediator in psoriasis? Cytokine 2006 33 2 72 78 2-s2.0-33644984835 10.1016/j.cyto.2005.12.001
25. Groves R. W., Sherman L., Mizutani H., Dower S. K., Kupper T. S., Detection of interleukin-1 receptors in human epidermis: induction of the type II receptor after organ culture and in psoriasis. The American Journal of Pathology 1994 145 5 1048 1056 2-s2.0-0027996250 (Pubitemid 24345653)
26. Anderson K. S., Petersson S., Wong J., Shubbar E., Lokko N. N., Carlström M., Enerbäck C., Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris. British Journal of Dermatology 2010 163 5 1085 1089 2-s2.0-78249235034 10.1111/j.1365-2133.2010.09990.x
27. Johnston A., Xing X., Guzman A. M., Riblett M., Loyd C. M., Ward N. L., Wohn C., Prens E. P., Wang F., Maier L. E., Kang S., Voorhees J. J., Elder J. T., Gudjonsson J. E., IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. The Journal of Immunology 2011 186 4 2613 2622 2-s2.0-79951821248 10.4049/jimmunol.1003162
28. Blumberg H., Dinh H., Dean C. Jr., Trueblood E. S., Bailey K., Shows D., Bhagavathula N., Aslam M. N., Varani J., Towne J. E., Sims J. E., IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. The Journal of Immunology 2010 185 7 4354 4362 2-s2.0-77958132740 10.4049/jimmunol.1000313
29. Dinarello C. A., Biologic basis for interleukin-1 in disease. Blood 1996 87 6 2095 2147 2-s2.0-0029979369 (Pubitemid 26086851)
30. Bachelez H., Immunopathogenesis of psoriasis: recent insights on the role of adaptive and innate immunity. Journal of Autoimmunity 2005 25 supplement 69 73 2-s2.0-28444493712 10.1016/j.jaut.2005.09.025 (Pubitemid 41728048)
31. Di Cesare A., Di Meglio P., Nestle F. O., The IL-23Th17 axis in the immunopathogenesis of psoriasis. Journal of Investigative Dermatology 2009 129 6 1339 1350 2-s2.0-67349230808 10.1038/jid.2009.59
32. + regulatory T cells allows for their purification from expansion cultures. Blood 2009 113 21 5125 5133 2-s2.0-65549168545 10.1182/blood-2009-01-199950
33. Deknuydt F., Bioley G., Valmori D., Ayyoub M., IL-1 β and IL-2 convert human Treg into T H 17 cells. Clinical Immunology 2009 131 2 298 307 2-s2.0-64149086421 10.1016/j.clim.2008.12.008